AKRX

Akorn, Inc. News Headlines

$38.06
*  
0.35
0.91%
Get AKRX Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading AKRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AKRX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
AxoGen, Inc. (AXGN) Jumps 5.45% on Insider Buying - Tale of the Tape
12/19/2014 9:18:00 AM - Zacks.com


Dr. Reddy's Laboratories (RDY) in Focus: Stock Falls 7.1% - Tale of the Tape
12/17/2014 9:06:00 AM - Zacks.com


3 Companies Growing Faster Than MannKind Corporation
12/17/2014 7:03:02 AM - Motley Fool


Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog
12/16/2014 6:20:00 PM - Zacks.com


Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog
12/16/2014 6:20:00 AM - Investopedia


Why Akorn (AKRX) is Poised to Beat Earnings Estimates Again - Tale of the Tape
12/15/2014 9:03:00 AM - Zacks.com


Actavis Likely to Continue Selling Namenda IR Tablets - Analyst Blog
12/12/2014 3:20:00 PM - Zacks.com


Supernus Faces another Patent Challenge for Oxtellar XR - Analyst Blog
12/11/2014 3:20:00 PM - Zacks.com


Supernus Faces New Patent Challenge for Trokendi XR - Analyst Blog
12/10/2014 2:50:00 PM - Zacks.com


Actavis' Antibiotic Backed for FDA Approval, Response in Q1 - Analyst Blog
12/8/2014 6:30:00 PM - Zacks.com


Actavis Launches Generic of Shire's ADHD Drug Intuniv - Analyst Blog
12/2/2014 6:45:00 PM - Zacks.com


Teva First to Launch a Generic of Novartis' Exforge HCT - Analyst Blog
12/2/2014 4:30:00 PM - Zacks.com


First Week of January 2015 Options Trading For Akorn (AKRX)
11/25/2014 11:59:41 AM - BNK Invest


Supernus Pharmaceuticals (SUPN) in Focus: Stock Up 9.8% - Tale of the Tape
11/19/2014 9:32:00 AM - Zacks.com


Corium International (CORI) Jumps: Stock Moves 14.3% Higher - Tale of the Tape
11/19/2014 9:25:00 AM - Zacks.com


Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
11/18/2014 1:00:00 PM - Investopedia


Synageva Up on New Phase III Data on Sebelipase Alfa - Analyst Blog
11/14/2014 3:40:00 PM - Zacks.com


Akorn (AKRX) Worth Watching: Stock Adds 6.4% in Session - Tale of the Tape
11/14/2014 8:51:00 AM - Zacks.com


Zacks Rank #1 Additions for Thursday - Tale of the Tape
11/13/2014 9:30:00 AM - Zacks.com


Zacks Rank #1 Additions for Tuesday - Tale of the Tape
11/11/2014 9:30:00 AM - Zacks.com


Akorn Q3 14 Earnings Conference Call At 10:00 AM ET
11/6/2014 9:00:00 AM - RTT News


Akorn Posts Loss In Q3; Adj. EPS Beats View - Quick Facts
11/6/2014 8:18:00 AM - RTT News


Meet The 5 Companies Loving Obamacare
11/4/2014 8:04:00 AM - Investopedia


Lannett Co. Gets Growth Rx In Generic Drugs Group
10/27/2014 4:59:00 PM - Investor's Business Daily


Interesting AKRX Put And Call Options For June 2015
10/23/2014 11:17:31 AM - BNK Invest